Dalio’s Bridgewater: Major Stocks Positions and New Buys in Q1


May. 22 2019, Published 11:08 a.m. ET


Ray Dalio’s Bridgewater Associates made several stock purchases during the first quarter. However, the stock purchases’ size compared to the fund’s ETF holdings is very small. Biogen (BIIB) was Bridgewater’s largest stock holding. Biogen contributed 0.35% of the fund’s total holdings. Bridgewater increased its position in the stock 424% during the first quarter. Bridgewater first took a stake in Biogen in the first quarter of 2018.

On March 21, Biogen and Eisai issued a press release announcing the termination of their aducanumab research program aimed at the drug study for Alzheimer’s disease. After the news, Biogen stock fell ~30%.

Article continues below advertisement

Major stock positions

Other major stocks positions and their portfolio weight at the end of the first quarter were:

  • Bristol Myers Squibb (BMY): 0.29%
  • Alliance Data Systems (ADS): 0.28%
  • Eastman Chemical (EMN): 0.28%
  • United Rentals (URI): 0.26%
  • Macy’s (M): 0.23%

New buys during the first quarter

The fund’s largest new buys during the first quarter were:


More From Market Realist

    • CONNECT with Market Realist
    • Link to Facebook
    • Link to Twitter
    • Link to Instagram
    • Link to Email Subscribe
    Market Realist Logo
    Do Not Sell My Personal Information

    © Copyright 2021 Market Realist. Market Realist is a registered trademark. All Rights Reserved. People may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.